Search results
Cambridge journal ‘pandering to mad Americans’ by ditching Anglo-Saxon from title
Daily Telegraph· 3 days agoWanjiru Njoya, a former lecturer at Oxford and Exeter and now an academic in the US, also addressed...
Expat grants won’t fix Brazilian research
Nature· 6 days agoPermanent jobs and fairer hiring practices would encourage overseas scientists to return.
Google DeepMind’s Groundbreaking AI for Protein Structure Can Now Model DNA
Wired News· 4 days agoGoogle spent much of the past year hustling to build its Gemini chatbot to counter ChatGPT, pitching...
Aaron Raey Joins PERFECT CRIME Off-Broadway
Broadway World· 3 days agoBeginning Friday, Aaron Ramey will star as Detective James Ascher in NYC’s Longest Running Play, Perfect Crime, now playing Off-Broadway at the Anne L....
'Low' risk and tests for all? Botched COVID response hangs over feds' bird-flu plans
Just the News· 5 days agoA shadowy virus is spreading with unknown frequency and risk to humans. The Centers for Disease...
Walton group buys 2,700 acres in Bella Vista; assures community input in future development - Talk...
Talk Business & Politics· 3 days agoBella Vista’s status as a go-to cycling and mountain biking destination might be overshadowed by...
Fishers mayor hopeful for busier year at Geist Waterfront Park - Indianapolis Business Journal
Indianapolis Business Journal· 2 days agoIn its first year, Fishers’ $16 million Geist Waterfront Park saw thousands fewer visitors than the...
Though noncitizens can vote in few local elections, GOP goes big to make it illegal
Ohio Capital Journal via Yahoo News· 3 days agoPreventing people who are not United States citizens from casting a ballot has reemerged as a focal...
What’s up with… NTT Docomo, Vodafone & Three, UScellular
TelecomTV· 2 days agoIn today’s industry news roundup: Japanese telco NTT Docomo is to pitch its services to the world...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 3 days agoCompany to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated
